Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.

Wareham DW, Momin MHFA, Phee LM, Hornsey M, Standing JF.

J Antimicrob Chemother. 2019 Oct 16. pii: dkz420. doi: 10.1093/jac/dkz420. [Epub ahead of print]

PMID:
31617905
2.

A novel plasmid-mediated polymyxin resistance determinant (mcr-1.8) in Escherichia coli recovered from broiler chickens in Brunei Darussalam.

Abdul Momin MHF, Liakopoulos A, Bean DC, Phee LM, Wareham DW.

J Antimicrob Chemother. 2019 Aug 23. pii: dkz352. doi: 10.1093/jac/dkz352. [Epub ahead of print] No abstract available.

PMID:
31504534
3.

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii.

Phee LM, Kloprogge F, Morris R, Barrett J, Wareham DW, Standing JF.

J Antimicrob Chemother. 2019 Apr 1;74(4):961-969. doi: 10.1093/jac/dky524.

4.

Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devices.

Wareham DW, Phee LM, Abdul Momin MHF.

J Antimicrob Chemother. 2018 Jul 1;73(7):1997-1998. doi: 10.1093/jac/dky095. No abstract available.

PMID:
29579199
5.
6.

Optimal detection of carbapenemase-producing Enterobacteriaceae from rectal samples: a role for enrichment?

Ciesielczuk H, Phee LM, Dolphin H, Wilks M, Cherian BP, Wareham DW.

J Hosp Infect. 2018 Mar;98(3):270-274. doi: 10.1016/j.jhin.2017.10.012. Epub 2017 Oct 23.

PMID:
29074053
7.

CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens.

Abdul Momin MHF, Bean DC, Hendriksen RS, Haenni M, Phee LM, Wareham DW.

J Med Microbiol. 2017 Nov;66(11):1554-1561. doi: 10.1099/jmm.0.000602. Epub 2017 Oct 6.

PMID:
28984232
8.

Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam.

Abdul Momin MHF, Liakopoulos A, Phee LM, Wareham DW.

J Glob Antimicrob Resist. 2017 Jun;9:96-99. doi: 10.1016/j.jgar.2017.02.008. Epub 2017 Apr 27.

PMID:
28458051
9.

Rifaximin combined with polymyxins: A potential regimen for selective decontamination of multidrug-resistant bacteria in the digestive tract?

Betts JW, Phee LM, Wareham DW.

J Glob Antimicrob Resist. 2016 Mar;4:11-15. doi: 10.1016/j.jgar.2015.11.008. Epub 2015 Dec 23.

PMID:
27436386
10.

Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.

Oikonomou O, Liakopoulos A, Phee LM, Betts J, Mevius D, Wareham DW.

Microb Drug Resist. 2016 Jul;22(5):379-86. doi: 10.1089/mdr.2015.0215. Epub 2016 Jan 26.

PMID:
27380549
11.

Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae.

Wareham DW, Shah R, Betts JW, Phee LM, Momin MH.

J Clin Microbiol. 2016 Feb;54(2):471-3. doi: 10.1128/JCM.02900-15. Epub 2015 Nov 25.

12.

In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.

Betts JW, Sharili AS, Phee LM, Wareham DW.

J Nat Prod. 2015 Aug 28;78(8):2145-8. doi: 10.1021/acs.jnatprod.5b00471. Epub 2015 Aug 12.

PMID:
26267658
13.

Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.

Phee LM, Betts JW, Bharathan B, Wareham DW.

Antimicrob Agents Chemother. 2015 Aug;59(8):4544-50. doi: 10.1128/AAC.00753-15. Epub 2015 May 18.

14.

Comparative virulence of urinary and bloodstream isolates of extra-intestinal pathogenic Escherichia coli in a Galleria mellonella model.

Ciesielczuk H, Betts J, Phee L, Doumith M, Hope R, Woodford N, Wareham DW.

Virulence. 2015;6(2):145-51. doi: 10.4161/21505594.2014.988095.

15.

Flexible endoscopic robot.

Lomanto D, Wijerathne S, Ho LK, Phee LS.

Minim Invasive Ther Allied Technol. 2015 Feb;24(1):37-44. doi: 10.3109/13645706.2014.996163. Review.

PMID:
25627436
16.

Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability.

Makena A, Brem J, Pfeffer I, Geffen RE, Wilkins SE, Tarhonskaya H, Flashman E, Phee LM, Wareham DW, Schofield CJ.

J Antimicrob Chemother. 2015 Feb;70(2):463-9. doi: 10.1093/jac/dku403. Epub 2014 Oct 16.

17.

Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia.

Betts JW, Phee LM, Woodford N, Wareham DW.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1565-72. doi: 10.1007/s10096-014-2101-3. Epub 2014 Apr 30.

PMID:
24781003
18.

In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.

Betts JW, Phee LM, Hornsey M, Woodford N, Wareham DW.

Antimicrob Agents Chemother. 2014 Jun;58(6):3541-6. doi: 10.1128/AAC.02449-14. Epub 2014 Mar 31.

19.

In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens.

Hornsey M, Phee L, Stubbings W, Wareham DW.

Int J Antimicrob Agents. 2013 Oct;42(4):343-6. doi: 10.1016/j.ijantimicag.2013.05.010. Epub 2013 Jul 7.

PMID:
23837926
20.

In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.

Phee L, Hornsey M, Wareham DW.

Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1291-4. doi: 10.1007/s10096-013-1875-z. Epub 2013 Apr 23.

PMID:
23609511
21.

In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.

Hornsey M, Phee L, Longshaw C, Wareham DW.

Int J Antimicrob Agents. 2013 Mar;41(3):285-7. doi: 10.1016/j.ijantimicag.2012.11.013. Epub 2013 Jan 9.

PMID:
23312607
22.

Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase.

Hornsey M, Phee L, Woodford N, Turton J, Meunier D, Thomas C, Wareham DW.

J Clin Pathol. 2013 Apr;66(4):348-50. doi: 10.1136/jclinpath-2012-201234. Epub 2013 Jan 2.

PMID:
23288920
23.

In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens.

Hornsey M, Longshaw C, Phee L, Wareham DW.

Antimicrob Agents Chemother. 2012 Jun;56(6):3080-5. doi: 10.1128/AAC.05870-11. Epub 2012 Apr 9.

24.

A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom.

Hornsey M, Phee L, Wareham DW.

Antimicrob Agents Chemother. 2011 Dec;55(12):5952-4. doi: 10.1128/AAC.05108-11. Epub 2011 Sep 19.

25.

Energy sources and their development for application in medical devices.

Rasouli M, Phee LS.

Expert Rev Med Devices. 2010 Sep;7(5):693-709. doi: 10.1586/erd.10.20. Review.

PMID:
20822391
26.

Master-slave robotic system for therapeutic gastrointestinal endoscopic procedures.

Low SC, Tang SW, Thant ZM, Phee L, Ho KY, Chung SC.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:3850-3.

PMID:
17945810
27.

Locomotion techniques for robotic colonoscopy.

Kassim I, Phee L, Ng WS, Gong F, Dario P, Mosse CA.

IEEE Eng Med Biol Mag. 2006 May-Jun;25(3):49-56. Review. No abstract available.

PMID:
16764431
28.

Analysis and development of locomotion devices for the gastrointestinal tract.

Phee L, Accoto D, Menciassi A, Stefanini C, Carrozza MC, Dario P.

IEEE Trans Biomed Eng. 2002 Jun;49(6):613-6.

PMID:
12046707

Supplemental Content

Support Center